For the Second Consecutive Year, TYSON GROUP Makes the Inc. 5000 with a Whopping Three-Year Revenue Growth of 236 Percent
August 20, 2024 10:21 ET
|
Tyson Group
DUBLIN, Ohio, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Inc. revealed last week that Tyson Group ranks No. 2210 on the 2024 Inc. 5000, its annual list of the fastest-growing private companies in America....
VCI Global Announces 44% Revenue Growth in Its Financial Results for the Six Months Ended June 30, 2024; Announces US$10 Million Share Repurchase Program Over 2 Years
August 19, 2024 08:26 ET
|
VCI Global Limited
KUALA LUMPUR, Malaysia, Aug. 19, 2024 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (Frankfurt: H0T) (“VCI Global,” “VCIG,” or the “Company”), a diversified holding company specializing in...
Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024
August 16, 2024 09:00 ET
|
Cannara Biotech (Québec) Inc.
Cannara Biotech announces record-breaking July revenues and schedules an investor webcast for August 20, 2024. Join at 2 PM ET for Q3 updates and a live QA
Tyson Group Announces the Addition of Dr. Adam Rapp to Enhance Sales Performance Solutions
August 15, 2024 09:21 ET
|
Tyson Group
DUBLIN, Ohio, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Tyson Group is proud to announce the addition of Dr. Adam Rapp to their team as Vice President of Research Integration. As a seasoned expert in sales...
Kneat Announces Record Revenue for Second Quarter 2024
August 06, 2024 17:17 ET
|
kneat.com, inc.
Kneat's Q2 2024 Growth Accelerates YoY, with Revenue up 45%, Annual Recurring Revenue up 60%, Gross Profit up 63%
Cannara Biotech publie ses résultats financiers pour le troisième trimestre de 2024
July 23, 2024 08:30 ET
|
Cannara Biotech (Québec) Inc.
Les produits bruts du cannabis avant les taxes d’accise ont augmenté pour atteindre 26,2 millions de dollars au troisième trimestre 2024, contre 20,6 millions de dollars au troisième trimestre 2023,...
Cannara Biotech Reports Q3 2024 Financial Results
July 23, 2024 08:30 ET
|
Cannara Biotech (Québec) Inc.
Net revenues up 22.6% to $19.5M, positive Adjusted EBITDA of $2.8M and operating cash flows of $4.3 million. Focused on the Canadian Cannabis Opportunity
KULR Experiences Fast-Growing Demand for Next-Gen EV Battery Safety and Testing Solutions with Order from Top Japanese Automaker
May 29, 2024 08:30 ET
|
KULR Technology Group, Inc.
Battery Testing and Analysis Services Unit to Generate $8 Million to $10 Million Revenue Annually Starting in 2025
MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration
May 16, 2024 16:40 ET
|
Mangoceuticals, Inc.
Dallas, Texas, May 16, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health...
Kneat Announces Record Revenue for First Quarter 2024
May 08, 2024 17:33 ET
|
kneat.com, inc.
Kneat maintains 35% year-over-year revenue growth to surpass $10 million quarterly revenue mark, as annual recurring revenue growth accelerates to 57%.